{"retracted":false,"update":{"timestamp":1491004800000,"doi":"10.1016/j.rec.2016.11.034","type":"erratum"},"doi":"10.1016/j.recesp.2016.11.044","journal":"Revista Española de Cardiología (English Edition)","publisher":"Elsevier BV","title":"Correction to the Article by Dalama et al. “New Oral Hypoglycemic Agents and Cardiovascular Risk. Crossing the Metabolic Border”. Rev Esp Cardiol . 2016;69:1088-1097"}
